Ngozi Nwobi
Psychiatric/Mental Health · Hamilton, NJNPI 1518294404
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 249 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 249 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$985
- AbbVie$747
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$437
- Teva Pharmaceuticals USA, Inc.$418
- Takeda Pharmaceuticals U.S.A., Inc.$312
- Alkermes, Inc.$224
- plus $1K from 14 others
What the payments were for
- Food & beverage$4,09698%
- Education$732%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 42 | $985 |
| AbbVie | 69 | $747 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $437 |
| Teva Pharmaceuticals USA, Inc. | 13 | $418 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $312 |
| Alkermes, Inc. | 14 | $224 |
| Otsuka America Pharmaceutical, Inc. | 14 | $191 |
| Supernus Pharmaceuticals, Inc. | 6 | $123 |
| Tris Pharma Inc | 8 | $117 |
| Lundbeck LLC | 8 | $113 |
| Vanda Pharmaceuticals Inc. | 8 | $112 |
| Gilead | 1 | $105 |
| Johnson & Johnson | 5 | $84 |
| Corium, LLC | 5 | $70 |
| Sunovion Pharmaceuticals Inc. | 3 | $43 |
| Neurocrine Biosciences, Inc. | 2 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Indivior Inc. | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| OWP Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,168 in reported general payments places this provider in the 90th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 78 | $2,774 |
| Aripiprazole | 49 | $1,497 |
| Buspirone Hcl | 24 | $945 |
| Duloxetine Hcl | 75 | $871 |
| Quetiapine Fumarate | 73 | $808 |
| Alprazolam | 121 | $705 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 25 | $604 |
| Lamotrigine | 39 | $398 |
| Bupropion Hcl | 36 | $363 |
| Fluoxetine Hcl | 26 | $345 |
| Methylphenidate Hcl | 20 | $345 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $324 |
| Oxcarbazepine | 17 | $306 |
| Clonazepam | 48 | $233 |
| Bupropion XlBupropion Hcl | 33 | $211 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Hamilton
- Chioma ObiukwuHamilton$8K
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.